studi
took
place
landspitali
univers
hospit
reykjavik
iceland
luh
luh
provid
secondari
care
inhabit
reykjavik
nearbi
town
compris
nation
popul
also
provid
intens
care
countri
adult
year
admit
decemb
novemb
screen
inclus
inclus
criteria
new
chest
xray
infiltr
addit
symptom
temperatur
diaphoresi
chill
new
cough
chest
pain
new
onset
dyspnea
exclus
criteria
follow
admiss
acut
care
facil
preced
day
use
immunosuppress
medic
corticosteroid
equival
mg
prednisolon
daili
methotrex
hydroxyurea
adalimumab
infliximab
etenercept
azathioprin
mycophenol
mofetil
cyclosporin
ongo
treatment
malign
receipt
solid
organ
transplant
human
immunodefici
viru
infect
potenti
particip
approach
within
hour
admiss
underw
structur
interview
data
collect
underli
diseas
subject
symptom
antimicrobi
use
admiss
pneumonia
sever
index
psi
score
calcul
outcom
length
stay
lo
admiss
intens
care
unit
icu
assist
ventil
inhous
mortal
outcom
obtain
retrospect
patient
chart
vital
statu
crosscheck
nation
registri
data
discharg
hospit
studi
nonintervent
includ
addit
diagnost
sampl
sputum
blood
obtain
cultur
prior
inhospit
antimicrobi
treatment
urin
antigen
test
perform
oropharyng
swab
collect
pcr
analysi
result
physicianord
etiolog
diagnost
test
also
includ
sputum
blood
cultur
routin
method
suscept
test
use
clinic
laboratori
standard
institut
method
criteria
result
highqual
sputum
sampl
includ
urin
antigen
test
use
commerci
avail
test
binaxnow
streptococcu
pneumonia
binaxnow
legionella
inver
medic
innov
oropharyng
swab
frozen
immedi
batch
analysi
pcr
step
sampl
initi
test
season
pandem
influenza
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
previous
describ
sampl
store
reanalyz
multiplex
realtim
pcr
pneumonia
haemophilu
influenza
influenza
b
rhinoviru
adenoviru
parainfluenza
respiratori
syncyti
viru
rsv
coronaviru
enteroviru
metapneumoviru
bocaviru
c
pneumonia
pneumonia
previous
describ
result
realtim
pcr
pneumonia
h
influenza
consid
posit
cycl
threshold
less
exclud
falseposit
result
due
carriag
studi
approv
luh
ethic
committe
accord
revis
declar
helsinki
inform
consent
obtain
individu
particip
proxi
includ
studi
statist
calcul
perform
use
ibm
spss
statist
version
ibm
corpor
incid
calcul
averag
popul
deriv
public
avail
offici
data
statist
iceland
http
wwwhagstofaishagtolurmannfjoldi
categor
data
compar
use
fisher
exact
test
appropri
continu
data
compar
confid
interv
ci
risk
factor
examin
conjunct
specif
etiolog
result
pneumonia
pneumonia
influenza
direct
comparison
detail
well
multinomi
logist
regress
variabl
includ
analysi
age
sex
underli
diseas
asthma
chronic
obstruct
pulmonari
diseas
ischem
heart
diseas
heart
failur
diabet
mellitu
type
underli
neurolog
diseas
chronic
renal
failur
malign
smoke
statu
recent
use
antimicrobi
influenza
vaccin
pneumococc
vaccin
fever
cough
purul
cough
hemoptysi
pleurit
chest
pain
sweat
dyspnea
stomach
pain
diarrhea
case
approach
suspect
pneumonia
chose
particip
gave
consent
case
meet
criteria
pneumonia
exclus
criteria
present
case
thu
admiss
includ
studi
potenti
case
cohort
describ
tabl
overal
incid
cap
requir
hospit
admiss
case
per
adult
per
year
detail
incid
figur
display
tabl
potenti
pathogen
identifi
case
multipl
agent
detect
case
tabl
commonli
identifi
organ
pneumonia
case
respiratori
viru
recov
case
atyp
bacteri
agent
pneumonia
c
pneumonia
legionella
speci
recov
case
addit
burkholderia
pseudomallei
detect
instanc
travel
return
southeast
asia
among
case
multipl
pathogen
detect
n
common
combin
pneumonia
viru
spneumonia
detect
influenza
case
rhinoviru
case
rsv
case
see
tabl
sputum
cultur
posit
case
avail
sampl
howev
particip
could
provid
adequ
sampl
comparison
blood
cultur
yield
relev
result
case
polymeras
chain
reaction
analysi
avail
sampl
result
identif
atyp
bacteri
pathogen
virus
addit
possibl
case
pneumonia
possibl
case
h
influenza
detect
use
pcr
pneumonia
case
confirm
method
wherea
case
h
influenza
confirm
method
pneumonia
h
influenza
identifi
addit
case
respect
use
multiplex
pcr
cycl
threshold
thu
exclud
analysi
complet
set
sampl
avail
case
tabl
etiolog
agent
detect
case
multipl
pathogen
identifi
case
pneumonia
h
influenza
identifi
greater
rate
among
patient
without
recent
antibiot
use
wherea
pneumonia
detect
frequent
among
patient
recent
antimicrobi
use
tabl
admiss
rate
due
pneumonia
stabl
studi
period
howev
viral
activ
separ
peak
viral
pathogen
detect
admiss
februari
octob
later
peak
coincid
influenza
pandem
patient
characterist
probabl
microbi
etiolog
shown
tabl
comparison
hamper
low
number
particip
group
patient
pneumonia
influenza
younger
lower
rate
underli
diseas
compar
group
mean
age
pneumonia
case
year
mean
age
influenza
case
year
compar
year
entir
group
tabl
despit
low
averag
age
case
pneumonia
year
age
agespecif
incid
pneumonia
admiss
highest
among
oldest
patient
tabl
symptom
similar
regardless
detect
agent
compar
occurr
underli
risk
factor
symptom
display
tabl
etiolog
directli
regress
analysi
pneumonia
like
found
patient
without
recent
antimicrobi
use
p
fisher
exact
test
odd
ratio
ci
p
associ
appear
stronger
pcr
result
exclud
ci
p
signific
direct
comparison
p
fisher
exact
test
convers
pneumonia
like
identifi
recent
antibiot
use
report
p
fisher
exact
test
link
also
found
regress
analysi
ci
p
likelihood
identifi
influenza
higher
amongst
vaccin
influenza
compar
directli
p
fisher
exact
test
regress
analysi
ci
p
hemoptysi
report
influenza
case
influenza
case
hemoptysi
caus
n
associ
hemoptysi
signific
case
compar
particip
p
fisher
exact
test
psi
score
lowest
patient
atyp
bacteri
infect
influenza
tabl
mortal
low
death
despit
higher
rate
cultur
obtain
patient
pathogen
detect
case
h
influenza
pneumonia
respect
length
stay
similar
group
patient
admit
icu
receiv
ventil
care
similar
rate
signific
differ
patient
differ
pathogen
detect
direct
comparison
tabl
use
regress
analysi
result
shown
major
strength
studi
high
inclus
rate
well
defin
popul
allow
direct
assess
incid
cap
requir
hospit
admiss
studi
perform
introduct
conjug
pneumococc
vaccin
nation
childhood
immun
program
make
import
refer
point
studi
author
knowledg
previou
studi
analyz
incid
pneumonia
requir
hospit
admiss
conjunct
etiolog
test
util
pcr
similar
scope
takahashi
et
al
found
incid
cap
vietnam
case
per
adult
result
difficult
compar
western
studi
due
differ
healthcar
system
addit
base
much
younger
popul
recent
studi
jain
et
al
recruit
elig
adult
patient
estim
overal
incid
cap
case
per
adult
per
year
similar
result
comparison
torr
et
al
recent
determin
review
overal
incid
cap
europ
approxim
per
popul
sever
studi
publish
last
decad
util
nucleic
acid
amplif
techniqu
assess
etiolog
pneumonia
recent
prospect
studi
unit
state
demonstr
pneumonia
account
pneumonia
requir
admiss
compar
studi
possibl
explan
may
jain
et
al
recov
highqual
sputum
sampl
particip
compar
studi
anoth
contribut
factor
may
widespread
vaccin
conjug
pneumococc
vaccin
us
popul
introduc
iceland
studi
perform
anoth
smaller
studi
set
unit
state
found
pneumonia
cohort
similar
result
europ
holter
et
al
recent
recov
pneumococci
admit
cap
patient
norway
conjug
pneumococc
vaccin
includ
childhood
vaccin
program
also
note
result
nasopharyng
cultur
upper
airway
pcr
omit
rate
similarli
bonten
et
al
found
cap
case
among
year
age
due
pneumonia
use
pcr
diagnost
anoth
recent
studi
gadsbi
et
al
achiev
pathogen
detect
patient
use
pcr
method
sputum
sampl
pneumonia
identifi
case
comparison
work
difficult
howev
gadsbi
et
al
exclud
patient
unabl
produc
sputum
recent
studi
support
result
current
studi
cap
due
pneumonia
uniqu
etiolog
pneumonia
examin
popul
reykjavik
simultan
studi
undertaken
year
current
work
found
pneumonia
caus
case
appar
decreas
may
part
due
fact
smoke
risk
factor
cap
invas
pneumococc
diseas
decreas
popul
interven
period
decreas
pneumonia
studi
current
one
also
line
declin
rate
pneumococc
pneumonia
last
centuri
review
succinctli
musher
et
al
previous
illustr
repeat
studi
popul
author
knowledg
rate
pneumonia
rel
high
studi
ie
identifi
case
comparison
jain
et
al
gadsbi
et
al
identifi
pneumonia
respect
cohort
wherea
holter
et
al
found
pathogen
patient
result
may
due
ongo
local
epidem
studi
period
question
requir
studi
younger
patient
rel
like
pneumonia
influenza
infect
studi
although
pneumonia
infect
known
common
younger
individu
approxim
one
third
case
among
older
patient
studi
highest
incid
group
mycoplasma
pneumonia
also
implic
sever
pneumonia
miyashita
et
al
found
patient
sever
diseas
requir
icu
admiss
studi
patient
pneumonia
receiv
icu
care
comparison
patient
pneumonia
admit
icu
although
pneumonia
identifi
diagnos
case
virus
also
commonli
recov
wherea
atyp
bacteria
found
previou
studi
found
viral
pathogen
patient
cap
influenza
common
viru
case
infect
pandem
strain
admit
octob
previous
shown
elderli
popul
rel
protect
pandem
influenza
strain
like
due
crossreact
immun
respons
found
patient
report
receiv
antibiot
admiss
similar
previou
report
prior
antibiot
use
associ
detect
pneumonia
correl
note
previous
possibl
reflect
lack
therapeut
respons
empir
antimicrobi
therapi
pneumonia
outpati
set
commonli
consist
would
worthi
studi
convers
odd
identifi
pneumonia
increas
patient
without
recent
antimicrobi
use
also
possibl
particip
receiv
prior
treatment
drawn
symptom
indic
differ
etiolog
previou
studi
exclud
patient
unabl
produc
sputum
recent
antimicrobi
use
improv
diagnost
yield
result
includ
vast
major
elig
patient
indic
approach
may
introduc
major
select
bia
exclud
infect
caus
atyp
bacteria
virus
preferenti
includ
pneumonia
caus
pneumonia
despit
diagnost
attempt
find
etiolog
patient
studi
common
recent
studi
found
etiolog
patient
reason
unclear
import
area
studi
studi
indic
likelihood
detect
pandem
influenza
increas
patient
report
hemoptysi
strain
associ
sever
diseas
season
influenza
blood
sputum
report
first
influenza
case
mexico
wherea
hemorrhag
tracheiti
bronchiti
note
histolog
featur
sever
case
prior
influenza
pandem
report
symptom
similar
group
help
discern
differ
etiolog
lack
correl
symptom
etiolog
demonstr
previous
confirm
result
mortal
rel
low
compar
mani
previou
studi
possibl
due
differ
set
inclus
criteria
jain
et
al
found
similar
mortal
cohort
similar
psi
score
despit
younger
wherea
patient
admit
icu
requir
invas
ventil
correspond
result
studi
respect
case
due
pandem
exclud
tabl
convers
median
lo
day
studi
jain
et
al
compar
current
studi
probabl
reflect
major
differ
manag
approach
problem
nordic
countri
unit
state
holter
et
al
examin
norwegian
cohort
ident
median
age
found
similar
lo
day
although
admit
icu
mortal
like
system
factor
differ
threshold
icu
admiss
time
switch
intraven
oral
transfer
outpati
manag
may
explain
differ
rate
icu
admiss
use
assist
ventil
lo
similar
patient
irrespect
organ
identifi
notabl
patient
atyp
pathogen
lower
psi
score
patient
requir
similar
icu
care
lo
score
includ
age
risk
factor
rel
low
age
influenza
pneumonia
patient
may
offer
partial
explan
sever
score
outcom
also
similar
patient
identifi
viru
compar
patient
although
pandem
influenza
case
heavili
influenc
result
account
morbid
group
patient
dual
pathogen
trend
toward
wors
outcom
number
patient
low
therefor
great
potenti
type
ii
error
studi
sever
limit
similar
studi
potenti
etiolog
identifi
sizeabl
group
particip
despit
high
level
patient
inclus
abl
collect
test
particip
complet
sampl
set
might
result
detect
potenti
pathogen
chose
collect
oropharyng
swab
pcr
analysi
optim
sampl
collect
patient
recruit
possibl
use
nasopharyng
sampl
may
increas
sensit
respiratori
virus
addit
organ
identifi
upper
airway
alway
assum
caus
agent
pneumonia
pcr
result
organ
must
interpret
suggest
possibl
etiolog
also
possibl
method
batch
analysi
storag
may
decreas
sensit
laboratori
method
compar
statist
result
studi
number
relev
variabl
comparison
cohort
size
particularli
individu
etiolog
must
kept
mind
compar
studi
appli
multinomi
regress
part
analysi
risk
overfit
due
small
number
individu
outcom
cohort
size
number
variabl
result
direct
comparison
report
alongsid
result
must
also
interpret
number
comparison
mind
factor
increas
risk
type
error
populationbas
studi
inclus
rate
demonstr
incid
cap
requir
hospit
case
per
adultsyear
pneumonia
frequent
identifi
pathogen
incid
pneumonia
highest
amongst
oldest
patient
similar
pathogen
examin
studi
design
exclud
particip
prior
antibiot
use
unabl
produc
sputum
increas
diagnost
yield
may
lead
bias
result
miss
certain
pathogen
clinic
sign
symptom
limit
use
identifi
patient
respiratori
viru
atyp
bacteri
infect
despit
lower
sever
score
among
patient
lo
rate
icu
admiss
need
assist
ventil
similar
regardless
microbi
etiolog
